1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)


Table 3: 
Association of major procedural complications and clinical factors
Major Procedural ComplicationsYes, n (%)No, n (%)P
Age, 22–64 y8 (13.8%)50 (86.2%).80
Age, 65+ y10 (11.6%)76 (88.4%)
Duration of symptoms <4 hours3 (11.5%)23 (88.5%).68
Duration of symptoms 4–6 hours7 (10.9%)57 (89.1%)
Duration of symptoms 6+ hours5 (14.7%)29 (85.3%)
NIHSS score 0–101 (12.5%)7 (87.5%).81
NIHSS score 11–2012 (12.0%)88 (88.0%)
NIHSS score >205 (13.9%)31 (86.1%)
IV tPA contraindicated8 (10.5%)68 (89.5%).46
IV tPA failed10 (15.2%)56 (84.8%)
Atrial fibrillation11 (14.7%)64 (85.3%).46
No atrial fibrillation7 (10.1%)62 (89.9%)